SAN FRANCISCO, March 30, 2026 /PRNewswire/ -- Deeplumen, the global leader in Marketing-to-AI (M2AI) infrastructure, today announced the launch of the Open Commerce Protocol (OCP). Built natively within the OpenClaw ecosystem, OCP is the very first protocol of its kind—an open Schema Contract Layer designed to power the next generation of the agentic economy.
From E-commerce to Agentic Commerce: A Revolution for Brands
In practical terms, OCP allows AI agents to complete transactions on behalf of users across platforms. OCP represents a fundamental shift from traditional e-commerce. While e-commerce focused on digital storefronts for human browsing, OCP enables brands to provide unified, end-to-end commerce services directly to AI agents like OpenClaw. This upgrade allows brands to transcend platform silos and offer a seamless transaction experience across a previously fragmented digital landscape.
Enabling Personal Shopping Assistants via OpenClaw
As a foundational protocol within the OpenClaw ecosystem, OCP provides the standardized commerce framework that allows any AI agent to function as a sophisticated personal shopping assistant. By implementing OCP, developers can now equip their agents with the "language" of trade, allowing users to enjoy fully agentic transaction execution—from product discovery to final delivery—handled by their personal AI representative.
The Three-Pillar Framework: Powering the Agentic Transaction Lifecycle
The OCP architecture ensures that every agentic interaction satisfies three essential steps: Discovery, Intention, Deal. The protocol also supports dual-mode operations across all layers: processing structured Merchant Profiles for precision, or inferring capabilities from existing web environments for broader compatibility.
- Discovery: Facilitates distributed entity and service discovery. Agents, like OpenClaw, autonomously identify verified brands and confirm their capabilities—such as checkout or identity linking—without central oversight.
- Intention: Manages the evolution of buyer intent and merchant requirements. This layer handles complex constraints, budget windows, and interactive escalations for scenarios requiring human approval at the final step.
- Deal: Executes binding commitments and secure payment settlements across distributed nodes. Using an append-only event ledger, OCP ensures a verifiable record of transactions across the full lifecycle, including shipping, returns, and customer service disputes.
Completing the Agentic Commerce Infrastructure
The launch of OCP marks the third and most critical milestone in Deeplumen's mission to build the infrastructure of the M2AI era. This protocol serves as the Schema Contract Layer of a comprehensive full-stack solution:
- UCP for Java (The Protocol Layer): Enabling legacy Java-based commerce systems to seamlessly integrate with AI agents.
- Agentic Page (The Content Layer): Providing specialized "storefronts" optimized for AI crawling and understanding.
- OCP (The Schema Contract Layer): The world's first open protocol defining how agents discover, negotiate, and execute commerce within the OpenClaw ecosystem.
About Deeplumen
Deeplumen is an AI-first technology company focused on the intersection of AI agents and agentic commerce. As the pioneers of the M2AI framework, Deeplumen builds the protocols and infrastructure that allow brands to thrive in the agentic economy.
Availability
** This press release is distributed by PR Newswire through automated distribution system, for which the client assumes full responsibility. **
Deeplumen Launches Open Commerce Protocol (OCP), Completing the Full-Stack Infrastructure for Agentic Commerce
|
- Korea–Thailand spine experts jointly lead advanced training on endoscopic spine surgery and lateral lumbar interbody fusion techniques
- Hands-on experience with Korean spine medical devices lays the foundation for advancing Asia's spine education hub
SEOUL, South Korea and BANGKOK, March 30, 2026 /PRNewswire/ -- CGBIO, a regenerative medicine-focused biomedical company led by CEO Hyun Seung Yu, announced on the 2nd that it recently hosted the "International Minimally Invasive Spine Surgery Education Forum (MEET THE MIS MASTERS: A Joint Korea–Thailand Forum)" at the Orthopaedic Learning Center, Faculty of Medicine, Siriraj Hospital in Bangkok, Thailand.
The forum was designed to provide leading spine surgeons across Asia with hands-on experience using the latest Korean-developed spine medical devices in Thailand, where demand for spinal surgery is rapidly increasing due to population aging and the growing prevalence of spinal disorders.
Beyond academic exchange, the forum was particularly meaningful as it helped establish a foundation for providing minimally invasive spine surgery to local patients—reducing surgical incisions and enabling faster recovery.
The event was co-hosted by The Catholic University of Korea and Chulalongkorn University, with support from the Ministry of Health and Welfare of Korea, the Korea Health Industry Development Institute (KHIDI), and Seongnam City.
More than 50 spine surgeons from eight Asian countries, including Korea and Thailand, participated, and the course directors were Professor Jin Sung Kim of Seoul St. Mary's Hospital, The Catholic University of Korea, and Professor Wicharn Yingsakmongkol of Chulalongkorn University.
The two-day program consisted of lectures on endoscopic spine surgery (biportal and uniportal techniques) and Oblique Lumbar Interbody Fusion (OLIF), cadaver-based hands-on training simulating real clinical environments, case studies, and clinical discussions.
Participants were divided into small groups to practice advanced techniques firsthand, share clinical application experiences, and strengthen academic and professional networks.
Through this initiative, the forum facilitated the dissemination of the latest minimally invasive spine surgery knowledge, strengthened collaboration and academic networks between Korean and Thai experts, and laid the groundwork for future joint research initiatives and procedural standardization.
CGBIO operated two of the six cadaver training stations and led hands-on education focused on biportal endoscopic decompression and interbody fusion.
The sessions were instructed by Professor Yong San Koh of Kyungpook National University Hospital, Director Sang Hyun Han of Asan Chungmu Hospital Spine Center, Professor Asrafi Rizki Gatam of Fatmawati General Hospital (Indonesia), and Professor Javier of Hospital Angeles Centro Sur (Mexico).
Participants directly used CGBIO products, including the bone graft substitute NOVOSIS, the expandable cage ExCender, and the minimally invasive screw system Colonnade, allowing them to assess firsthand the safety and competitiveness of Korean spine medical devices.
The hands-on training is also expected to enhance participants' surgical proficiency and clinical safety.
Professor Jin Sung Kim of Seoul St. Mary's Hospital, The Catholic University of Korea, stated, "Since 2022, the Korea Medical Device Education and Training Support Center initiative has steadily evolved through the development of educational content, clinical validation of surgical products, and professional training programs, as well as expanded domestic academic exchange. Building on the experience and expertise accumulated over the years, it is particularly meaningful to now actively support Korean companies in strengthening their competitiveness and growth in overseas markets. We will continue to provide academic support to facilitate their global expansion and export growth."
Hyun Seung Yu, CEO of CGBIO, stated, "This forum was meaningful in that it went beyond technical training and provided overseas spine surgeons with direct experience using Korean spine medical devices. The fact that technologies developed in Korea were applied in real surgical training settings and recognized for their effectiveness by medical professionals serves as clear evidence that Korean medical devices can meaningfully contribute to improving patient outcomes across Asia."
He added, "Building on this experience, CGBIO will expand international academic exchange and establish a global education network, positioning itself as a trusted spine surgery education hub and a leading representative of Korean medical devices not only in Asia but worldwide."
- Korea–Thailand spine experts jointly lead advanced training on endoscopic spine surgery and lateral lumbar interbody fusion techniques
- Hands-on experience with Korean spine medical devices lays the foundation for advancing Asia's spine education hub
SEOUL, South Korea and BANGKOK, March 30, 2026 /PRNewswire/ -- CGBIO, a regenerative medicine-focused biomedical company led by CEO Hyun Seung Yu, announced on the 2nd that it recently hosted the "International Minimally Invasive Spine Surgery Education Forum (MEET THE MIS MASTERS: A Joint Korea–Thailand Forum)" at the Orthopaedic Learning Center, Faculty of Medicine, Siriraj Hospital in Bangkok, Thailand.
The forum was designed to provide leading spine surgeons across Asia with hands-on experience using the latest Korean-developed spine medical devices in Thailand, where demand for spinal surgery is rapidly increasing due to population aging and the growing prevalence of spinal disorders.
Beyond academic exchange, the forum was particularly meaningful as it helped establish a foundation for providing minimally invasive spine surgery to local patients—reducing surgical incisions and enabling faster recovery.
The event was co-hosted by The Catholic University of Korea and Chulalongkorn University, with support from the Ministry of Health and Welfare of Korea, the Korea Health Industry Development Institute (KHIDI), and Seongnam City.
More than 50 spine surgeons from eight Asian countries, including Korea and Thailand, participated, and the course directors were Professor Jin Sung Kim of Seoul St. Mary's Hospital, The Catholic University of Korea, and Professor Wicharn Yingsakmongkol of Chulalongkorn University.
The two-day program consisted of lectures on endoscopic spine surgery (biportal and uniportal techniques) and Oblique Lumbar Interbody Fusion (OLIF), cadaver-based hands-on training simulating real clinical environments, case studies, and clinical discussions.
Participants were divided into small groups to practice advanced techniques firsthand, share clinical application experiences, and strengthen academic and professional networks.
Through this initiative, the forum facilitated the dissemination of the latest minimally invasive spine surgery knowledge, strengthened collaboration and academic networks between Korean and Thai experts, and laid the groundwork for future joint research initiatives and procedural standardization.
CGBIO operated two of the six cadaver training stations and led hands-on education focused on biportal endoscopic decompression and interbody fusion.
The sessions were instructed by Professor Yong San Koh of Kyungpook National University Hospital, Director Sang Hyun Han of Asan Chungmu Hospital Spine Center, Professor Asrafi Rizki Gatam of Fatmawati General Hospital (Indonesia), and Professor Javier of Hospital Angeles Centro Sur (Mexico).
Participants directly used CGBIO products, including the bone graft substitute NOVOSIS, the expandable cage ExCender, and the minimally invasive screw system Colonnade, allowing them to assess firsthand the safety and competitiveness of Korean spine medical devices.
The hands-on training is also expected to enhance participants' surgical proficiency and clinical safety.
Professor Jin Sung Kim of Seoul St. Mary's Hospital, The Catholic University of Korea, stated, "Since 2022, the Korea Medical Device Education and Training Support Center initiative has steadily evolved through the development of educational content, clinical validation of surgical products, and professional training programs, as well as expanded domestic academic exchange. Building on the experience and expertise accumulated over the years, it is particularly meaningful to now actively support Korean companies in strengthening their competitiveness and growth in overseas markets. We will continue to provide academic support to facilitate their global expansion and export growth."
Hyun Seung Yu, CEO of CGBIO, stated, "This forum was meaningful in that it went beyond technical training and provided overseas spine surgeons with direct experience using Korean spine medical devices. The fact that technologies developed in Korea were applied in real surgical training settings and recognized for their effectiveness by medical professionals serves as clear evidence that Korean medical devices can meaningfully contribute to improving patient outcomes across Asia."
He added, "Building on this experience, CGBIO will expand international academic exchange and establish a global education network, positioning itself as a trusted spine surgery education hub and a leading representative of Korean medical devices not only in Asia but worldwide."
** This press release is distributed by PR Newswire through automated distribution system, for which the client assumes full responsibility. **
CGBIO Showcases Minimally Invasive Spine Surgery Techniques in Thailand: "Smaller Incisions, Faster Recovery"
CGBIO Showcases Minimally Invasive Spine Surgery Techniques in Thailand: "Smaller Incisions, Faster Recovery"
